Sponsor:
City of Hope Medical Center
Code:
NCT06059391
Conditions
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia, BCR-ABL1 Positive
Hematopoietic and Lymphoid System Neoplasm
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
Allogeneic Hematopoietic Stem Cell Transplantation
Biospecimen Collection
Granulocyte Colony-Stimulating Factor
Hematopoietic Cell Transplantation Conditioning Regimen
Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-10. This information was provided to ClinicalTrials.gov by City of Hope Medical Center on 2025-03-11.